Patents by Inventor DG Bostwick

DG Bostwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunologic Treatment of Cancer
    Publication number: 20240058049
    Abstract: Provided herein are new compositions, methods, and devices to treat cancer through a combination of immunologic chemotherapeutic agents and ablation techniques. These compositions can include immune checkpoint inhibitors, cytokines and nucleic acid drugs that aid in eliciting an immune response to treat the tumor. The administration of these compositions in addition to various ablating techniques provides a presentation of the cancer cell antigens to the immune system and the immunologic targeting of the cancer.
    Type: Application
    Filed: March 27, 2023
    Publication date: February 22, 2024
    Inventors: Gary Onik, James A. Miessau, DG Bostwick
  • Immunologic treatment of cancer
    Patent number: 11612426
    Abstract: Provided herein are new compositions, methods, and devices to treat cancer through a combination of immunologic chemotherapeutic agents and ablation techniques. These compositions can include immune checkpoint inhibitors, cytokines and nucleic acid drugs that aid in eliciting an immune response to treat the tumor. The administration of these compositions in addition to various ablating techniques provides a presentation of the cancer cell antigens to the immune system and the immunologic targeting of the cancer.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: March 28, 2023
    Assignee: ImmunSys, Inc.
    Inventors: Gary Onik, James A. Miessau, DG Bostwick
  • Immunologic Treatment of Cancer
    Publication number: 20200040095
    Abstract: Provided herein are new compositions, methods, and devices to treat cancer through a combination of immunologic chemotherapeutic agents and ablation techniques. These compositions can include immune checkpoint inhibitors, cytokines and nucleic acid drugs that aid in eliciting an immune response to treat the tumor. The administration of these compositions in addition to various ablating techniques provides a presentation of the cancer cell antigens to the immune system and the immunologic targeting of the cancer.
    Type: Application
    Filed: October 9, 2019
    Publication date: February 6, 2020
    Inventors: Gary Onik, DG Bostwick
  • IMMUNOLOGIC TREATMENT OF CANCER
    Publication number: 20190023804
    Abstract: Provided herein are new compositions, methods, and devices to treat cancer through a combination of immunologic chemotherapeutic agents and ablation techniques. These compositions can include immune checkpoint inhibitors, cytokines and nucleic acid drugs that aid in eliciting an immune response to treat the tumor. The administration of these compositions in addition to various ablating techniques provides a presentation of the cancer cell antigens to the immune system and the immunologic targeting of the cancer.
    Type: Application
    Filed: January 13, 2017
    Publication date: January 24, 2019
    Inventors: Gary Onik, James A. Miessau, DG Bostwick